StockData
Regen BioPharma Inc logo

Regen BioPharma Inc (RGBP) stock

RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 2/30
$0.00+0.00 (+50.00%)

Close on Oct 19, 2026Market cap $92.33KP/E –Yield –

Regen BioPharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Regen BioPharma's price to sales ratio was 0.7× on Oct 19, 2026, against 1.7× a year earlier. Over the last 4 years it ranged from 0.0× to 409.1×, with a median of 4.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.7×−0.5
2025Dec 31, 20251.2×−0.3
2024Dec 31, 20241.6×−5.5
2023Dec 29, 20237.0×−71.1
2022Dec 30, 202278.2×−140.7
2020Jul 31, 2020218.9×–

More Regen BioPharma figures

See a number that looks wrong?